midostaurin has been researched along with Gastritis* in 2 studies
2 other study(ies) available for midostaurin and Gastritis
| Article | Year |
|---|---|
Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.
Midostaurin is a tyrosine multikinase inhibitor approved for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) with mutated Fms-like tyrosine kinase-3. We describe a case report of a 49-year-old AML patient treated with an intensive chemotherapy regimen followed by midostaurin. After achieving complete remission with blood count recovery, he suffered from a serious, rare complication of necrotizing hemorrhagic gastritis with no evidence of infection or malignant infiltration, possibly associated with midostaurin therapy. Topics: Abdominal Pain; Gastritis; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Protein Kinase Inhibitors; Remission Induction; Staurosporine; Tomography, X-Ray Computed | 2020 |
Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?
Topics: Acute Disease; Gastritis; Humans; Leukemia, Myeloid, Acute; Staurosporine | 2020 |